<DOC>
	<DOCNO>NCT00405977</DOCNO>
	<brief_summary>The aim study investigate whether optimize pre-treatment intravenous magnesium enhances speed onset standard intubation dose rocuronium .</brief_summary>
	<brief_title>The Effect Magnesium Sulphate Time Course Rocuronium Induced Neuromuscular Block</brief_title>
	<detailed_description>In previous study pre-treatment intravenous MgSO4 60 mg kg-1 show impact onset action rocuronium [ Kussmann et al , 1997 ] . Yet , study , MgSO4 inject bolus induction anaesthesia , one minute injection neuromuscular blocking agent . We suppose magnesium need time penetrate neuromuscular endplate shift Mg/Ca ratio favor magnesium . Thus , particular design previous study may explain magnesium scope enhance speed onset action rocuronium . The aim study investigate whether optimised pre-treatment magnesium ( short infusion rather bolus injection ; reasonable delay administration magnesium subsequent injection neuromuscular block agent ) enhance speed onset standard intubation dose rocuronium . 1 . Preanaesthetic preparation - Solid food liquid intake allow minimum six hour induction - Patients premedicated 7.5 mg oral midazolam 45 min prior induction - Standard monitor consist : ECG , SaO2 , ETCO2 , non-invasive blood pressure , rectal oesophageal T° 2 . Study drug administration - Intravenous infusion study solution , 1 ml per kg bodyweight , correspond MgSO4 60 mg kg-1 magnesium group . The infusion give Infusomat 15 minute . 3 . Induction maintenance anaesthesia - At end study drug infusion , preoxygenation period three minute , anaesthesia induce sufentanil 0.2µg kg-1 propofol , use Target Controlled Infusion ( TCI ) system ( Base Primea , Fresenius-Vial , Brezins , France ) pharmacokinetic model Schnider et al [ Schnider et al , 1999 ] . The initial effect site concentration 4 µg ml-1 . - Maintenance anaesthesia propofol effect site 4 . Neuromuscular monitoring - Neuromuscular function monitor use TOF Watch® SX ( NV Organon ) TOF nerve stimulation . The guideline good clinical research practice pharmacodynamic study NMBAs follow . - The ulnar nerve stimulate surface electrode , adductor pollicis muscle response measure . - After stabilisation period , rocuronium 0.6 mg kg-1 ( 2 x ED95 ) inject intravenously 5 second . - The trachea intubate 95 % depression first twitch 5.1 . Neuromuscular measurement - Onset time = time begin injection rocuronium 95 % depression first twitch ( T1 ) . - Duration 25 % = time begin injection rocuronium 25 % T1 recovery . - Recovery index T25-75 = time 25 % T1 recovery 75 % T1 recovery . - Clinical recovery T25 - 0.9 = time 25 % T1 recovery TOF ratio ( T1/T4 ) 0.9 ( correspond safe extubation condition ) . 5.2 . Haemodynamics - Blood pressure - Heart rate These measurement do ( baseline ) , 5-minute interval study drug infusion . Before immediately tracheal intubation , haemodynamic measurement repeat . 5.3 . Adverse event , safety - Any minor adverse event ( need intervention ) major adverse event record .</detailed_description>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<criteria>American Society Anaesthesiology ( ASA ) status I II Adults , age 18 year 60 year Scheduled elective surgery lasting longer 120 min without need continuous curarisation A history allergy hypersensitivity rocuronium Neuromuscular disease Preoperative medication know influence neuromuscular function ( instance , certain antibiotic anticonvulsant ) Electrolyte abnormalities Hepatic renal insufficiency Patients body mass index &lt; 19 &gt; 28 kg m2 Pregnant breastfeed woman Expected difficult intubation mask ventilation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Neuromuscular block</keyword>
	<keyword>Magnesium</keyword>
	<keyword>Rocuronium</keyword>
	<keyword>Time course action</keyword>
</DOC>